- Home
- MTX vs OCUL Comparison
MTX vs OCUL Comparison
Compare MTX & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTX
- OCUL
- Stock Information
- Founded
- MTX 1968
- OCUL 2006
- Country
- MTX United States
- OCUL United States
- Employees
- MTX N/A
- OCUL N/A
- Industry
- MTX Major Chemicals
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- MTX Industrials
- OCUL Health Care
- Exchange
- MTX Nasdaq
- OCUL Nasdaq
- Market Cap
- MTX 1.7B
- OCUL 1.8B
- IPO Year
- MTX 1992
- OCUL 2014
- Fundamental
- Price
- MTX $64.13
- OCUL $13.60
- Analyst Decision
- MTX Strong Buy
- OCUL Strong Buy
- Analyst Count
- MTX 2
- OCUL 6
- Target Price
- MTX $82.00
- OCUL $17.20
- AVG Volume (30 Days)
- MTX 207.6K
- OCUL 2.2M
- Earning Date
- MTX 10-23-2025
- OCUL 08-05-2025
- Dividend Yield
- MTX 0.69%
- OCUL N/A
- EPS Growth
- MTX N/A
- OCUL N/A
- EPS
- MTX 0.06
- OCUL N/A
- Revenue
- MTX $2,063,500,000.00
- OCUL $56,664,000.00
- Revenue This Year
- MTX N/A
- OCUL N/A
- Revenue Next Year
- MTX $4.53
- OCUL $18.87
- P/E Ratio
- MTX $1,029.52
- OCUL N/A
- Revenue Growth
- MTX N/A
- OCUL N/A
- 52 Week Low
- MTX $49.54
- OCUL $5.79
- 52 Week High
- MTX $86.49
- OCUL $13.82
- Technical
- Relative Strength Index (RSI)
- MTX 59.04
- OCUL 68.16
- Support Level
- MTX $63.24
- OCUL $12.41
- Resistance Level
- MTX $65.38
- OCUL $12.49
- Average True Range (ATR)
- MTX 1.46
- OCUL 0.56
- MACD
- MTX 0.04
- OCUL 0.04
- Stochastic Oscillator
- MTX 67.65
- OCUL 88.48
About MTX Minerals Technologies Inc.
Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of our customers' finished products. The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve our customers' manufacturing processes and projects. The majority of revenue comes from the United States.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.